Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Arcturus Therapeutics's peak revenue was $206.0M in 2022. The peak quarterly revenue was $160.3M in 2022(q4).
Arcturus Therapeutics's revenue increased from $15.8m in 2018 to $152.3M currently. That's a 866.86% change in annual revenue.
| Fiscal year / year | Arcturus Therapeutics revenue |
|---|---|
| 2018 | $15.8M |
| 2019 | $20.8M |
| 2020 | $9.5M |
| 2021 | $12.4M |
| 2022 | $206.0M |
| 2023 | $166.8M |
| 2024 | $152.3M |
Rate Arcturus Therapeutics' financial transparency
Arcturus Therapeutics saw the greatest revenue growth in 2022, when revenue increased by 1,566.79%.
Arcturus Therapeutics had the lowest revenue growth in 2020, when revenue changed by -54.12%.
| Year | Arcturus Therapeutics growth |
|---|---|
| 2019 | 32%↑ |
| 2020 | -54%↓ |
| 2021 | 30%↑ |
| 2022 | 1567%↑ |
| 2023 | -19%↓ |
| 2024 | -9%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | - | $10.2M | $3.3M | $3.0M |
| 2020 | $2.6M | $2.3M | $2.3M | $2.2M |
| 2021 | $2.1M | $2.0M | $2.4M | $5.8M |
| 2022 | $5.2M | $27.1M | $13.4M | $160.3M |
| 2023 | $80.3M | $9.5M | $45.1M | $25.1M |
| 2024 | $32.7M | $46.1M | $38.9M | $22.8M |
Do you work at Arcturus Therapeutics?
Is Arcturus Therapeutics transparent about its revenue structure?
| Industry | Software & Services |
| Company Type | Public |
| Employees Number | 150 |
| Date Founded | 2013 |
| Headquarters | San Diego, California |
| Revenue | $152.3M |
| Net Income | $9,349,000 |
| Tax Rate | 0.0% |
| Total Assets | $450,387,000 |
| Ticker | ARCT |
Arcturus Therapeutics received early financing of $580.0K on 2013-04-05.
| Series | Round size | Date |
|---|---|---|
| Seed | $580K | 04/2013 |
| Seed | $1.3M | 06/2013 |
| Series A | $5M | 10/2013 |
Arcturus Therapeutics's top competitor, Vertex Pharmaceuticals, earned an annual revenue of $11.0B.
Arcturus Therapeutics's smallest competitor is Advanced Proteome with revenue of $284.9K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Seagen | $85,008 | $2.0B | 900 | - |
| Sanofi Genzyme | $84,495 | $4.6B | 12,000 | - |
| Acorda Therapeutics | $97,279 | $117.6M | 344 | - |
| Emergent BioSolutions | $77,521 | $1.6B | 1,834 | 8 |
| Vaxart | $55,032 | $28.7M | 110 | - |
| Sarepta Therapeutics | $94,985 | $1.9B | 840 | 18 |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 106 |
| Med Immune Inc | $56,355 | $1.7B | 5,000 | - |
| Geron | $56,851 | $77.0M | 15 | - |
| Quidel | $71,489 | $1.7B | 1,500 | - |
Zippia gives an in-depth look into the details of Arcturus Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Arcturus Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Arcturus Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Arcturus Therapeutics. The data presented on this page does not represent the view of Arcturus Therapeutics and its employees or that of Zippia.
Arcturus Therapeutics may also be known as or be related to Arcturus Therapeutics, Arcturus Therapeutics Holdings Inc., Arcturus Therapeutics Ltd. and Arcturus Therapeutics, Inc.